Monografie
Discrimination between CMV infection and Alzheimer's disease as driving forces for immune senescence
- Sprache
-
Englisch
- Identifier
-
1162971444
Thema
Alzheimer's disease; Dementia; Amyloid; Infection; Durchflusscytometrie ; Immunologie ; Cytomegalie-Virus ; Alzheimer-Krankheit
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Objekttyp
- Monografie
Beteiligte
- Goldeck, David
- Pawelec, Graham
Ähnliche Objekte (12)
Role of Stem Cell Factor in the Development of Alzheimer's Disease
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Characterization of circulating microRNAs as potential biomarkers for dementia
BiTE Antikörper-Konstrukte zur Therapie von Influenza A- und Cytomegalovirus-Infektionen
Regulation of Alzheimer’s disease-relevant protein processing in human neurons of the LUHMES cell line
Mitochondrial alterations in different Alzheimers disease mouse models
Identification and characterization of IAPP derived inhibitors of cytotoxic self-assembly and amyloidogenesis of islet amyloid polypeptide (IAPP) and ß-amyloid [beta amyloid] peptide (Aß) [A beta]
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Modulation of Alzheimer's pathology in transgenic mouse models
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Identification of the cellular mechanisms undelying the contribution of stress and glucocorticoids to Alzheimer's disease pathology
Role of Stem Cell Factor in the Development of Alzheimer's Disease
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Characterization of circulating microRNAs as potential biomarkers for dementia
BiTE Antikörper-Konstrukte zur Therapie von Influenza A- und Cytomegalovirus-Infektionen
Regulation of Alzheimer’s disease-relevant protein processing in human neurons of the LUHMES cell line
Mitochondrial alterations in different Alzheimers disease mouse models
Identification and characterization of IAPP derived inhibitors of cytotoxic self-assembly and amyloidogenesis of islet amyloid polypeptide (IAPP) and ß-amyloid [beta amyloid] peptide (Aß) [A beta]
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Modulation of Alzheimer's pathology in transgenic mouse models
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions
Identification of the cellular mechanisms undelying the contribution of stress and glucocorticoids to Alzheimer's disease pathology
Role of Stem Cell Factor in the Development of Alzheimer's Disease
Modeling familial Alzheimer's disease utilizing gene targeted human induced pluripotent stem cells
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Characterization of circulating microRNAs as potential biomarkers for dementia
BiTE Antikörper-Konstrukte zur Therapie von Influenza A- und Cytomegalovirus-Infektionen
Regulation of Alzheimer’s disease-relevant protein processing in human neurons of the LUHMES cell line
Mitochondrial alterations in different Alzheimers disease mouse models
Identification and characterization of IAPP derived inhibitors of cytotoxic self-assembly and amyloidogenesis of islet amyloid polypeptide (IAPP) and ß-amyloid [beta amyloid] peptide (Aß) [A beta]
Vagus-evozierte Potentiale zur Frühdiagnose der Alzheimer-Erkrankung
Modulation of Alzheimer's pathology in transgenic mouse models
Building multiscale computable model of Alzheimer’s disease and identification of novel mechanisms for new therapeutic interventions